A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients
NCT00219076
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
504
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
aliskiren
Sponsor
Novartis